Dr Volberding has served on data and safety monitoring boards for Merck & Co, Inc. (Updated 05/23/19)

Constance A. Benson, MD
Dr Benson has served on advisory and data monitoring boards for GlaxoSmithKline/ViiV Healthcare and received research grants awarded to her institution from Gilead Sciences, Inc. Disclosure information for her spouse, Dr Schooley, is elsewhere on this page. (Updated 04/29/19)

Peter C. Cassat, JD
Mr Cassat has no relevant financial affiliations to disclose. (Updated 10/03/18)

Judith S. Currier, MD
Dr Currier has received grant support awarded to her institution from Theratechnologies. (Updated 03/28/19)

Carlos del Rio, MD
Dr del Rio has no relevant financial affiliations to disclose. (Updated 05/17/19)

Roy M. Gulick, MD, MPH
Dr Gulick has no relevant financial affiliations to disclose. (Updated 04/03/19)

Jeanne M. Marrazzo, MD, MPH, FACP, FIDSA
Dr Marrazzo has received research grants from Merck & Co, Inc, and Cepheid; served as an advisor to Gilead Sciences, Inc, and BioFire Diagnostics, and served on a data safety monitoring board for Gilead Sciences, Inc. (Updated 04/09/19)

Douglas D. Richman, MD
Dr Richman has been a consultant to Antiva Biosciences, Gilead Sciences, Inc, and Viriome, Inc. (Updated 03/21/19)

Michael S. Saag, MD
Dr Saag has received research grants and support awarded to his institution from Gilead Sciences, Inc and ViiV Healthcare. (Updated 03/29/19)

Robert T. Schooley, MD
Dr Schooley has served as a consultant to CytoDyn and Gilead Sciences, Inc. He has received grant support from Gilead Sciences, Inc, and holds stock or stock options in Antiva Biosciences and CytoDyn. Disclosure information for his spouse, Dr Benson, is elsewhere on this page. (Updated 04/02/19)

Donna M. Jacobsen, BS
Ms Jacobsen has no relevant financial affiliations to disclose. (Updated 05/23/19)